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The aim of the present study was to assess the effects of Jin Batu (Strobilanthes
crispus) leaves extract (1 % w/w) on diet-induced obese rats and to evaluate its
potential development for the treatment of obesity. S. crispus leaves were
extracted in chloroform-methanol (3:5), and the extracts were given in drinking
water of obese rats. This experiment was divided into 2 phases. In the first phase,
Sprague-Dawley rats (n=42) aged 4 months old (mature age) were given semi-
purified high-fat (HF) diet for 14 weeks to induce obesity. In the second phase,
Obese rats were treated for another 14 weeks with 1% (w/w) chloroform-
methanol extract ofS. crispus leaves.
Results obtained in the first phase were as follows. After 14 weeks of HF diet, 18
diet-induced rats were identified as obese based on the body weight gain. The
obese rats had significantly (p <0.05) higher energy intake, adipose tissue and
liver weights and plasma leptin levels compared to Normal rats. Obese rats also
had higher feed efficiency and lower adipose tissue lipolysis and lipoprotein
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lipase (LPL) gene expression than Normal rats. A severe case of fatty liver (non-
alcoholic fatty liver disease) with the development of hepatic steatosis was also
noted in Obese rats. No significant difference was found in mean food intake,
HDL, LDL, cholesterol, triglyceride, glucose, glycerol and insulin levels between
Normal and Obese rats.
In the second phase, Obese rats from HF diet treatment were divided into two
groups; Obese and Obese + Treatment (OT). The use of Normal rats as positive
control in the first phase was continued in the second phase. Only OT group was
given S. crispus extract (1 % w/w) in drinking water. High-Fat diet (during first
phase) was switched to normal rat chow diet for all groups to imitate diet
modification as a method of therapy in human. After 14 weeks of treatment with
S. crispus extract, OT group was found to have lower mean body weight than
control Obese group. The mean body weight gain and feed efficiency was also
lowest in OT group when compared to Normal and Obese groups. However, for
both results the difference was not significant. The anti-obesity effect of OT
group was further confirmed with significantly (p <0.05) lower adipose tissue and
liver weight and leptin level compared to Obese group. Lower glucose level and
hepatic steatosis combined with high lipolysis rate and LPL mRNA expressed in
adipose tissue was also noted in OT group.
In conclusion, this study indicates that 1% (w/w) S. crispus extract has some anti-
obesity effect on obese rats especially in decreasing adipose tissue weight,
lowering leptin level and hepatic steatosis.
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Kajian ini dijalankan bertujuan untuk menilai kesan ekstrak (1 % w/w) daun Jin
Batu (Strobilanthes crispus) terhadap tikus obes yang teraruh melalui diet tinggi
lemak. Daun S. crispus telah diekstrak dalam larutan kloroform-metanol (3:5) dan
kemudiannya dimasukkan ke dalam air minuman tikus obes. Kajian ini telah
dibahagikan kepada 2 fasa. Dalam fasa pertama, tikus Sprague-Dawley (n=42)
berumur 4 bulan (umur matang) telah diberikan diet berlemak tinggi (semi-tulen)
selama 14 minggu untuk menjadikannya obes. Dalam fasa kedua, tikus obes telah
diberikan 1% (w/w) ekstrak kloroform-metanol daun S. crispus selama 14
minggu.
Setelah 14 minggu diberikan diet berlemak tinggi, 18 ekor tikus telah .
diidentifikasikan sebagai obes berdasarkan pertambahan berat badannya. Didapati
tikus obes tersebut mempunyai jumlah pengambilan tenaga dari makanan yang
lebih tinggi secara signifikan (p <0.05) berbanding tikus normal. Di samping itu,
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berat tisu adipos, berat hati dan kandungan leptin dalam plasma darah tikus obes
turut didapati lebih tinggi dan signifikan (p <0.05) berbanding tikus normal.
Kadar pengekspresan gen lipoprotein lipase (LPL) turut didapati lebih tinggi
dalam tisu adipos tikus obes berbanding tikus normal walaupun ianya tidak
signifikan. Kes hati berlemak yang kronik turut diperhatikan dalam tikus obes.
Variabel lain yang dikaji seperti jumlah pengambilan makanan, profil darah (aras
HDL, LDL, kolesterol dan trigliserida), aras glukosa, aras gliserol dan insulin
plasma didapati tidak jauh berbeza dalam kedua-dua kumpulan obes dan normal.
Dalam eksperimen fasa kedua, tikus obes dari eksperimen fasa pertama telah
diambil dan dibahagikan kepada dua kumpulan yang diberi nama kumpulan
Obese (sebagai kawalan) dan kumpulan Obese + Treatment (OT). Penggunaan
tikus Normal sebagai kawalan positif dalam fasa pertama juga diteruskan dalam
fasa kedua. Hanya kumpulan OT yang diberi rawatan ekstrak daun S. crispus
melalui air minuman. Dalam semua kumpulan, diet berlemak tinggi yang
diberikan sebelum ini (fasa pertama) telah ditukar kepada diet makanan tikus
normal. Setelah 14 minggu ekstrak S. crispus diberikan kepada kumpulan OT,
kumpulan OT didapati mempunyai purata berat badan akhir yang lebih rendah
berbanding kumpulan Obese. Purata pertambahan berat badan dan efisiensi
pengambilan makanan kumpulan OT pula adalah yang paling rendah berbanding
kumpulan lain. Kesan anti-obesiti dalam kumpulan OT dibuktikan melalui berat
tisu adipos, berat hati dan paras leptin dalam plasma darah yang lebih rendah
dengan signifikan (p< 0.05) berbanding kumpuIan Obese. Selain itu, aras glukosa
yang rendah, pengurangan lemak dalam hati, kadar lipolisis yang tinggi dalam
v
adipos tisu dan jumlah pengekspresan gen yang tinggi dalam tisu adipos
berbanding kumpulan Obese turnt diperhatikan dalam kumpulan OT walaupun.
ianya tidak signifikan.
Secara kesimpulannya, kajian ini menunjukkan bahawa ekstrak 1% (w/w)
S.crispus mempunyai kesan anti-obesiti terhadap tikus obes terutamanya dalam
mengurangkan berat tisu adipos, aras leptin dan lemak dalam hati.
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CHAPTER 1
INTRODUCTION
International Diabetes Institute (2000) defined obesity as a condition in which
there is an excess of body fat while Bjorntorp (1998) specifically defined obesity
as an increased mass of total adipose tissue triglycerides. The operational
definitions of obesity and overweight however are based on body mass index
(BMI), which is closely correlated with body fatness. Body Mass Index is defined
as weight per height squared (kg/m2) (International Diabetes Institute, 2000).
Excessive body mass for stature, and more specifically an excessive body fat
content, is a condition of concern because it is in and of itself socially and
physically debilitating and it represents a risk factor for increased morbidity and
mortalility rate. It is now clear that a high body mass for height or a high body fat
level and upper body obesity plus weight gain in adult life are associated with the
risk of developing several chronic diseases (Bray et al., 1998).
In Malaysia, more than 6 million or about 20-28 percent of Malaysians are obese
and are at risk of developing serious diseases (Dtusan Malaysia, 2005). World
Food and Agriculture Organization (FAO) had stated that the obesity problem
arises as Malaysians consumed high calorie food daily especially food with high
fat content (Dtusan Malaysia, 2005). The Malaysia National Health Morbidity
Survey (1996) revealed that in adults, 20.7% were overweight and 5.8% obese
(0.3% of whom had BMI values of >40.0 kg m-2); the prevalence of obesity was
clearly greater in women than in men. In women, obesity rates were higher in
Indian and Malay women than in Chinese women, while in men the Chinese
recorded the highest obesity prevalence followed by the Malay and Indians (Lim
et al., 2000).
The remedies proposed over the years for losing body weight, or more precisely
body fat, are exhaustive and have essentially concentrated on traditional methods
aimed at manipulating food intake and/or increasing physical activity. Many
dietary regimens have been proposed with various permutations on the three
major energy-providing components of the diet (Dwyer, 1980), and although they
may work for a few individuals, the fact that overweight and obesity continue to
rise is evidence that they do not work for the vast majority who wish to lose or
maintain their lost weight. Increasing physical activity increases energy
expenditure and provides other health benefits; however, when one calculates the
amount of exercise that must be performed to lose a few grams of fat it must
appear a daunting task for someone who has 20 to 50 kg of excess fat to lose
(Garrow, 1995). The observations that most weight-reducing programs have a low
rate of success indicate that both diet and exercise have limited efficiency
(Acheson & Tappy, 2004). Failing, or in addition to, dietary management and
physical exercise, an individual can also use pharmaceutical aids to help control
body weight. However, the numbers of drugs that are presently approved for the
treatment ofobesity are relatively few (Bray, 2000).
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In the past a variety of drugs that influence appetite, energy expenditure, or both
were used; however, all have been found to cause serious side effects and are
considered inappropriate for the phannacological treatment of obesity (Acheson
& Tappy, 2004). At the present time Sibutramine, and Orlistat are In use.
Sibutramine, a beta-phanethylamine, is the only centrally acting anti-obesity
compound approved for use in most countries. Cardiovascular side effects include
an increase in systolic and diastolic blood pressure, and an increase in heart rate,
tachycardia and palpitations and vasodilatation (Halford, 2006). Weight loss
produced by sibutramine has a number of beneficial effects on key risk factors for
non-communicable diseases. However, perhaps the most critical issue is
cardiovascular function. Sibutramine has been shown to increase heart rate (3-7
beats per minute) and blood pressure. These adrenergic side effects are a
particular concern for patients with hypertension (Halford, 2006). Orlistat
(tetrahydrolipstatin) is a semi synthetic hydrogenated derivative of a naturally
occurring lipase inhibitor produced by Streptomyces toxytricini (Weibel et al.,
1987; Hochuli et al., 1987). This compound can block up to one-third of ingested
fat from being digested. This undigested fat is then eliminated in the bowel
movements. Side effects may include oily stools or spotting, increased number of
bowel movements, bowel movement urgency, poor bowel movement control, or
gas with discharge (Harp, 1998). Weight loss of 10% to 15% can decrease health
risks. However, failure to lose weight or failure to improve comorbid conditions
indicates either non-compliance with the drug or that the patient is not responding
to the drug. Either setting requires reevaluation of therapy and addition of other
medications or other modalities of treatment (Bray, 2000).
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Recently, there has been a marked increase in the use of preparations based on
medicinal plants in the developed countries, more so as these are generally
regarded as being free from the side effects associated with synthetic drugs
(Chada & Singh, 1991). Health care products, natural cosmetic, and health foods
are becoming increasingly popular. The observed efficacy of many traditional
medicines is another important reason for the revival of interest in medicinal
plants (Chada & Singh, 1991). A study ofthe Malaysian plants has yielded a large
harvest of natural products (Goh et al., 1995). Several international agencies are
now taking an interest in the promotion of the use and research on medicinal
plants in the developing countries (Chada & Singh, 1991). The World Health
Organization (WHO) supports such research programed (Hedberg, 1987). In the
declaration of WHO on primary health care for all by the year 2000, medicinal
plants have been assigned an important role (Chada & Singh, 1991).
Since the early years, the Malays have been using plant products such as the
leaves, roots, stems, flowers and fruit as ingredients in the preparation of
traditional medicine. Traditional medicine has been used since immemorial time
and until today, it remains a popular method of treatment. In the tropics, a total of
6,000 floral species have been reported to possess medicinal values (Muhamad &
Mustafa, 1994; Goh et al., 1995). From this, a total of 1,230 have been recorded
in Malaysia as plants used in traditional medicine. Scientific studies have proven
that several medicinal plants used in Malay traditional medicine indeed do contain
organic compounds which produce therapeutic effects, in other words, possess
medicinal values. Malaysia, a developing country, is rich in natural resources. We
4
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should not waste these resources by leaving them to grow wild only to be
destroyed, without utilizing them on a larger commercial basis (Muhamad &
Mustafa, 1994). Judging from the large amount of useful substances already
obtained from plants, and in view of the fact that only 7% of those now known to
science have been properly investigated, research in this area offers a wide scope
for the future (Hedberg, 1987).
Strobilanthes crispus plant is a native plant to countries from Madagascar to
Indonesia, and is commonly known as daun picah beling in Indonesia and enyoh
kelo, kecibeling or kejibeling in Jawa (Sunarto, 1977). This bush-like plant can be
found on riverbank or abandoned field while some Javanese use this plant as
fence. From a chemical investigation done by Ahmed Faress (1999), it was found
that the active compound of S. crispus is a phenolic acid named verbascoside.
Phenolic compounds have been shown to reduce plasma cholesterol and
triglycerides (Thompson, 1993).
Other than that, high level of total ash (21.6%) found in the dried plant leaves
were the result of high content of minerals such as potassium (10,900 mg/l00 g
sample), followed by calcium (5,185 mg/lOO g sample) (Maznah et al., 2000).
There were not many studies done to investigate the potential of S. crispus leaves
as medicinal plant. This research will look into the possible role of S. crispus
leaves as anti-obesity agent because of its high mineral contents. More recently, it
has been proposed that dietary calcium regulates energy metabolism and lipolysis
5
